Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J0583 Bivalirudin

J Codes (Drugs)

Also known as: bivalirudin, Angiomax, direct thrombin inhibitor

Bivalirudin injection, a direct thrombin inhibitor anticoagulant for systemic use in preventing thrombotic complications during cardiac procedures.

In Plain Language

blood thinner injection; anticoagulant medication

Clinical Context

Systemic anticoagulation for acute coronary syndromes and cardiac procedures. Direct thrombin inhibitor offering more predictable anticoagulation than heparin, particularly beneficial in HIT-positive patients.

RVU Information

CPT J0583 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

cardiologycritical carehospital medicine

Frequently Asked Questions

What is CPT code J0583?

CPT J0583 (Bivalirudin) is a J Codes (Drugs) code. Bivalirudin injection, a direct thrombin inhibitor anticoagulant for systemic use in preventing thrombotic complications during cardiac procedures.

How is J0583 administered?

CPT J0583 is administered by a healthcare provider, typically via injection or infusion. Systemic anticoagulation for acute coronary syndromes and cardiac procedures. Direct thrombin inhibitor offering more predictable anticoagulation than heparin, particularly beneficial in HIT-positive patients. It is used by cardiology, critical care, hospital medicine.

When is CPT J0583 used?

Systemic anticoagulation for acute coronary syndromes and cardiac procedures. Direct thrombin inhibitor offering more predictable anticoagulation than heparin, particularly beneficial in HIT-positive patients.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.